Related Experiment Videos
Local antivirals in a herpes simplex stromal keratitis model
Archives of Ophthalmology (Chicago, Ill. : 1960)
|April 1, 1979
Summary
Early topical antiviral treatment suppressed herpes simplex stromal keratitis in rabbits, but later treatment was ineffective, suggesting viral replication is key for initiation, not maintenance. Immunologic responses may control later stages.
Area of Science:
- Ophthalmology
- Virology
- Immunology
Background:
- Herpes simplex stromal keratitis (HSSK) is a significant cause of vision loss.
- Understanding the role of viral replication and host immune response in HSSK pathogenesis is crucial for effective treatment.
Purpose of the Study:
- To evaluate the efficacy of topical antivirals in managing HSSK in a rabbit model.
- To investigate the role of viral replication in the initiation and maintenance of HSSK.
Main Methods:
- An HSSK rabbit model was established via intrastromal injection of live herpes simplex virus.
- Topical trifluridine (trifluorothymidine) and vidarabine monophosphate (adenine arabinoside monophosphate) were administered early and frequently.
- Subconjunctival trifluridine was also tested. Disease progression and drug effects were monitored.
Main Results:
- Early and frequent topical administration of trifluridine and vidarabine monophosphate suppressed HSSK development.
- Neither drug showed significant efficacy when administered seven days after disease onset.
- Subconjunctival trifluridine was ineffective in treating HSSK.
Conclusions:
- Viral replication appears critical for initiating HSSK, as evidenced by early antiviral suppression.
- Antiviral therapy is less effective in later stages, suggesting viral multiplication is not the primary driver of established disease.
- Immunologic mechanisms likely play a significant role in controlling HSSK once the cornea is antigenically altered by the initial infection.